Another ViewCompletely agree that it shouldn't have fallen as far as it did in the first place. GLTA
Well Health has been doing "well" over the last couple of days with strong volume. Any particular news driving this and is now too late to buy? WELL is doing a broker road show this week (Thursday) and won a contract in early April. Two brokers upgraded the stock in late March but there has been no material recent news. Market cap has crossed back again over $1B. It also shifts into profitability this year and continues to grow sales nicely. We take the strength as a confirmation of quality, and don't really think it ever should have dropped as much as it did. We still like it. (5iResearch)